245 related articles for article (PubMed ID: 8002246)
1. Interleukin-1-beta changes the expression of metalloproteinases in the vitreous humor and induces membrane formation in eyes containing preexisting retinal holes.
Kosnosky W; Li TH; Pakalnis VA; Fox A; Hunt RC
Invest Ophthalmol Vis Sci; 1994 Dec; 35(13):4260-7. PubMed ID: 8002246
[TBL] [Abstract][Full Text] [Related]
2. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR.
Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM
Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176
[TBL] [Abstract][Full Text] [Related]
3. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro.
Martini B
Acta Ophthalmol Suppl (1985); 1992; (201):1-63. PubMed ID: 1322004
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.
Takano A; Hirata A; Inomata Y; Kawaji T; Nakagawa K; Nagata S; Tanihara H
Am J Ophthalmol; 2005 Oct; 140(4):654-60. PubMed ID: 16140249
[TBL] [Abstract][Full Text] [Related]
5. Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.
Schuettauf F; Haritoglou C; May CA; Rejdak R; Mankowska A; Freyer W; Eibl K; Zrenner E; Kampik A; Thaler S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3573-8. PubMed ID: 16877431
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and their inhibitors in human vitreous.
De La Paz MA; Itoh Y; Toth CA; Nagase H
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1256-60. PubMed ID: 9620087
[TBL] [Abstract][Full Text] [Related]
7. Ocular toxicity of intravitreal tacrolimus.
Passos E; Genaidy MM; Peyman GA
Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
[TBL] [Abstract][Full Text] [Related]
8. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294
[TBL] [Abstract][Full Text] [Related]
9. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
Snead DR; James S; Snead MP
Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural analysis of interleukin-1 beta-induced leukocyte recruitment to the rat retina.
Bamforth SD; Lightman SL; Greenwood J
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):25-35. PubMed ID: 9008627
[TBL] [Abstract][Full Text] [Related]
11. Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels.
Hunt RC; Fox A; al Pakalnis V; Sigel MM; Kosnosky W; Choudhury P; Black EP
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3179-86. PubMed ID: 8407227
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells.
Girard MT; Matsubara M; Fini ME
Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2441-54. PubMed ID: 1651296
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy.
Nakagawa M; Refojo MF; Marin JF; Doi M; Tolentino FI
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628
[TBL] [Abstract][Full Text] [Related]
14. The levels of cytokines and nitric oxide in rabbit vitreous humor after retinal laser photocoagulation.
Er H; Doganay S; Turkoz Y; Cekmen M; Daglioglu MC; Gunduz A; Evereklioglu C; Isci N
Ophthalmic Surg Lasers; 2000; 31(6):479-83. PubMed ID: 11095125
[TBL] [Abstract][Full Text] [Related]
15. The safety of intravitreal hyaluronidase. A clinical and histologic study.
Gottlieb JL; Antoszyk AN; Hatchell DL; Saloupis P
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2345-52. PubMed ID: 2242999
[TBL] [Abstract][Full Text] [Related]
16. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD
Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
[TBL] [Abstract][Full Text] [Related]
17. Treatment of stage 2 macular hole by intravitreous injection of expansile gas and induction of posterior vitreous detachment.
Mori K; Saito S; Gehlbach PL; Yoneya S
Ophthalmology; 2007 Jan; 114(1):127-33. PubMed ID: 17070585
[TBL] [Abstract][Full Text] [Related]
18. [Retinal detachment caused by macular holes in patients with severe myopia: results of intravitreal injection of pure C3F8].
Pernot A; Fleury J; Bonnet M
J Fr Ophtalmol; 1996; 19(8-9):491-5. PubMed ID: 8944130
[TBL] [Abstract][Full Text] [Related]
19. A new model of proliferative vitreoretinopathy.
Frenzel EM; Neely KA; Walsh AW; Cameron JD; Gregerson DS
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2157-64. PubMed ID: 9761295
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
Kon CH; Occleston NL; Charteris D; Daniels J; Aylward GW; Khaw PT
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
